DK2306202T3 - Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom - Google Patents

Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom

Info

Publication number
DK2306202T3
DK2306202T3 DK10196249.6T DK10196249T DK2306202T3 DK 2306202 T3 DK2306202 T3 DK 2306202T3 DK 10196249 T DK10196249 T DK 10196249T DK 2306202 T3 DK2306202 T3 DK 2306202T3
Authority
DK
Denmark
Prior art keywords
detecting
immunoglobulins
bound
monitoring
plasma cell
Prior art date
Application number
DK10196249.6T
Other languages
Danish (da)
English (en)
Inventor
Arthur Bradwell
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Application granted granted Critical
Publication of DK2306202T3 publication Critical patent/DK2306202T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK10196249.6T 2005-01-27 2006-01-26 Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom DK2306202T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody
EP06703629.3A EP1842071B3 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease

Publications (1)

Publication Number Publication Date
DK2306202T3 true DK2306202T3 (da) 2014-02-10

Family

ID=34259791

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10196249.6T DK2306202T3 (da) 2005-01-27 2006-01-26 Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom

Country Status (11)

Country Link
US (3) US7897353B2 (https=)
EP (2) EP1842071B3 (https=)
JP (3) JP5431674B2 (https=)
AT (1) ATE502302T1 (https=)
DE (1) DE602006020688D1 (https=)
DK (1) DK2306202T3 (https=)
ES (2) ES2455440T3 (https=)
GB (1) GB0501741D0 (https=)
PL (1) PL2306202T3 (https=)
PT (1) PT2306202E (https=)
WO (1) WO2006079816A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
RU2587621C2 (ru) 2009-04-01 2016-06-20 Дженентек, Инк. АНТИТЕЛА К FcRH5, ИХ ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001946D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201012049D0 (en) 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201203938D0 (en) 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
US12546782B2 (en) * 2013-03-15 2026-02-10 Mayo Foundation For Medical Education And Research Identification and monitoring of monoclonal immunoglobulins related to monoclonal gammopathy by molecular mass with mass spectrometry
CN105518380B (zh) 2013-09-06 2019-01-29 传感器电子技术股份有限公司 紫外线漫射照射
CA2944767C (en) 2014-04-04 2022-07-12 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
GB2541027A (en) * 2015-08-07 2017-02-08 The Binding Site Group Ltd Treatment
GB201603291D0 (en) * 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
US12153052B2 (en) 2017-09-13 2024-11-26 Mayo Foundation For Medical Education And Research Identification and monitoring of immunoglobulin J chains
US11946937B2 (en) 2017-09-13 2024-04-02 Mayo Foundation For Medical Education And Research Identification and monitoring of apoptosis inhibitor of macrophage
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
GB202007047D0 (en) * 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907502A (en) * 1973-12-11 1975-09-23 Miless L Brink Method for identifying Bence Jones proteins
EP0044219A1 (en) 1980-07-16 1982-01-20 Unilever Plc Methods of immuno analysis using monoclonal antibodies
JPS63139199A (ja) * 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
DE3856421T2 (de) 1987-04-27 2000-12-14 Unilever Nv Spezifische Bindungstestverfahren
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5185066A (en) * 1988-08-11 1993-02-09 Helena Laboratories Corporation Immunofixation electrophoresis control system
JPH03199966A (ja) * 1989-12-27 1991-08-30 Kazutomo Wakasugi 遊離型ｌ鎖の測定方法
JPH04262792A (ja) * 1990-01-12 1992-09-18 Takeda Chem Ind Ltd 蛋白質の精製法
US5228960A (en) * 1992-07-17 1993-07-20 Beckman Instruments, Inc. Analysis of samples by capillary electrophoretic immunosubtraction
US5552277A (en) * 1994-07-19 1996-09-03 The Johns Hopkins University School Of Medicine Genetic diagnosis of prostate cancer
ATE285417T1 (de) 1995-11-03 2005-01-15 Binding Site Ltd Herstellung von antikörpern
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies
EP1131344B1 (en) * 1998-11-19 2005-08-03 ELAN CORPORATION, Plc Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
IL157165A0 (en) * 2001-02-20 2004-02-08 Genset Sa Pg-3 and biallelic markers thereof
US20020182748A1 (en) 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein
EP1449851A4 (en) * 2001-11-27 2005-11-16 Mochida Pharm Co Ltd NEUTRALIZING ANTIBODIES OF IL13 ALPHA RECEPTOR 1
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
JP2007524361A (ja) * 2003-02-10 2007-08-30 アジェンシス， インコーポレイテッド 膀胱癌及びその他の癌の治療及び検出に有用な名称１５８ｐ１ｄ７の核酸及び対応タンパク質
JP5356648B2 (ja) * 2003-02-20 2013-12-04 シアトル ジェネティックス， インコーポレイテッド 抗ｃｄ７０抗体−医薬結合体、ならびに癌および免疫障害の処置のためのそれらの使用
ES2383014T3 (es) * 2003-04-02 2012-06-15 F. Hoffmann-La Roche Ag Anticuerpos contra el factor I de crecimiento similar a insulina y usos de los mismos
WO2005062044A1 (ja) * 2003-11-19 2005-07-07 Yamasa Corporation ベンスジョーンズ蛋白質の検定法
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein

Also Published As

Publication number Publication date
US20110177535A1 (en) 2011-07-21
ATE502302T1 (de) 2011-04-15
JP5715671B2 (ja) 2015-05-13
US20080166742A1 (en) 2008-07-10
EP2306202B1 (en) 2013-12-18
EP1842071B1 (en) 2011-03-16
JP5431674B2 (ja) 2014-03-05
US20110177977A1 (en) 2011-07-21
EP2306202A1 (en) 2011-04-06
EP1842071A1 (en) 2007-10-10
JP2014025950A (ja) 2014-02-06
JP6007134B2 (ja) 2016-10-12
JP2008528995A (ja) 2008-07-31
ES2365626T7 (es) 2014-06-04
PL2306202T3 (pl) 2014-05-30
US8592561B2 (en) 2013-11-26
US7897353B2 (en) 2011-03-01
JP2013147499A (ja) 2013-08-01
GB0501741D0 (en) 2005-03-02
US8415110B2 (en) 2013-04-09
DE602006020688D1 (de) 2011-04-28
ES2455440T3 (es) 2014-04-15
WO2006079816A1 (en) 2006-08-03
ES2365626T3 (es) 2011-10-07
EP1842071B3 (en) 2014-02-26
PT2306202E (pt) 2014-02-27

Similar Documents

Publication Publication Date Title
DK2306202T3 (da) Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom
ATE410684T1 (de) Molekular-modifikations-assays
ATE449337T1 (de) Assay
WO2009058902A3 (en) Methods and devices for analyte detection
WO2009117510A3 (en) Multi-wavelength analyses of sol-particle specific binding assays
WO2010049672A3 (en) Methods and products for measuring free immunoglobulin light chain molecules
WO2010096674A3 (en) A+ biomarker assays
BRPI0812878B8 (pt) anticorpo isolado ou parte funcional do mesmo, vetor, método para produzir um anticorpo ou uma parte funcional do mesmo, para produzir uma célula produtora de anticorpo e para produzir um anticorpo capaz de se ligar especificamente a rsv, composição, e, uso de um anticorpo ou parte funcional do mesmo ou de uma composição ou de vetor
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
Chocarro-Ruiz et al. Interferometric nanoimmunosensor for label-free and real-time monitoring of Irgarol 1051 in seawater
WO2005047863A3 (en) Substrates, devices, and methods for cellular assays
WO2008076367A3 (en) Polymer-protein substrates for immunosorbent fluorescence assays
ATE520029T1 (de) Biochemisches gerät und nachweisverfahren
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
WO2001073443A3 (en) Methods and compositions for the simultaneous detection of multiple analytes
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
ATE405837T1 (de) Festphase immunochromatographische testverfahren
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering
WO2002079783A3 (en) Method and device for testing for bence-jones protein
EP1258729A3 (en) A method of selecting an antibody, a hybridoma, a monoclonal antibody and use thereof
ATE405830T1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
ATE529749T1 (de) Chromatographische teststreifen für ein oder mehrere analyte
JP2018519525A5 (https=)
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου